Tokyo Tape
Sign in
← Otsuka Holdings

Half-year report · Q2

4578.TEDINET S100U5FO
Period2024-01-01 → 2024-06-30
Filed2024-08-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 56
MetricValuePeriodScopeSource row
Revenue¥1.11T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Revenue¥589.4bn2024-04-01 → 2024-06-30dCons.Revenue IFRS
Revenue¥2.02T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥947.5bn2023-01-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥499.2bn2023-04-01 → 2023-06-30dCons.Revenue IFRS
Operating income¥126.3bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Operating income¥34.3bn2024-04-01 → 2024-06-30dCons.Operating profit loss IFRS
Operating income¥130.7bn2023-01-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥53.9bn2023-04-01 → 2023-06-30dCons.Operating profit loss IFRS
Profit before tax¥142.2bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Profit before tax¥42.1bn2024-04-01 → 2024-06-30dCons.Profit loss before tax IFRS
Profit before tax¥142.7bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥138.8bn2023-01-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥59.6bn2023-04-01 → 2023-06-30dCons.Profit loss before tax IFRS
Net income (owners)¥107.8bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥30.4bn2024-04-01 → 2024-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥121.6bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥102.6bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.2bn2023-04-01 → 2023-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥110.6bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Net income¥31.7bn2024-04-01 → 2024-06-30dCons.Profit loss IFRS
Net income¥105.1bn2023-01-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥42.4bn2023-04-01 → 2023-06-30dCons.Profit loss IFRS
Total assets¥3.66Tat 2024-06-30Cons.Assets IFRS
Total assets¥3.36Tat 2023-12-31Cons.Assets IFRS
Total assets¥3.31Tat 2023-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥993.9bnat 2024-06-30Cons.Liabilities IFRS
Total liabilities¥924.9bnat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥2.67Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥2.44Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥2.47Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥2.26Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥2.62Tat 2024-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.39Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.43Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥485.9bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥513.3bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥498.7bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥471.6bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥133.0bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥283.2bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥113.5bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥159.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥190.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥54.3bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥26.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.3bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥46.8bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥198.612024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥56.032024-04-01 → 2024-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥224.12023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥189.062023-01-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥75.852023-04-01 → 2023-06-30dCons.Basic earnings loss per share IFRS
Equity ratio71.6%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.2%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.4%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 88
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥56.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-06-30¥29.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥54.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-06-30¥28.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-06-30¥880m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30¥4.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-06-30¥2.9bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥1.8bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-06-30−¥890m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥1.8bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-06-30−¥890m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥24.2bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-06-30−¥13.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2024-01-01 → 2024-06-30¥15.7bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2024-04-01 → 2024-06-30¥8.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2024-01-01 → 2024-06-30¥15.7bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2024-04-01 → 2024-06-30¥8.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥3m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2024-04-01 → 2024-06-30¥1m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2024-01-01 → 2024-06-30¥12.3bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2024-04-01 → 2024-06-30¥8.0bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥271.8bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2024-04-01 → 2024-06-30¥145.6bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥271.8bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2024-04-01 → 2024-06-30¥145.6bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥15m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2024-04-01 → 2024-06-30¥8m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥37.3bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2024-04-01 → 2024-06-30¥20.5bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥766.7bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2024-04-01 → 2024-06-30¥407.1bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥766.7bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2024-04-01 → 2024-06-30¥407.1bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥96.0bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2024-04-01 → 2024-06-30¥16.2bn
—segment totalrevenue2024-01-01 → 2024-06-30¥1.11T
—segment totalrevenue2024-04-01 → 2024-06-30¥590.3bn
—segment totalrevenue external2024-01-01 → 2024-06-30¥1.11T
—segment totalrevenue external2024-04-01 → 2024-06-30¥589.4bn
—segment totalrevenue intersegment2024-01-01 → 2024-06-30¥1.8bn
—segment totalrevenue intersegment2024-04-01 → 2024-06-30¥890m
—segment totalsegment profit2024-01-01 → 2024-06-30¥150.5bn
—segment totalsegment profit2024-04-01 → 2024-06-30¥47.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-06-30¥55.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥27.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-06-30¥53.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥26.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-06-30¥1.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥920m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-06-30¥4.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30¥1.5bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥965m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥965m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥25.4bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥12.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2023-01-01 → 2023-06-30¥17.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥9.2bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2023-01-01 → 2023-06-30¥17.4bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥9.2bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥9m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥4m
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2023-01-01 → 2023-06-30¥8.1bn
jpcrp040300-q2r_E21183-000Consumer Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥5.8bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2023-01-01 → 2023-06-30¥226.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue2023-04-01 → 2023-06-30¥122.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2023-01-01 → 2023-06-30¥226.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue external2023-04-01 → 2023-06-30¥122.2bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥54m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥40m
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2023-01-01 → 2023-06-30¥7.0bn
jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segmentsegment profit2023-04-01 → 2023-06-30−¥3.8bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-06-30¥650.4bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue2023-04-01 → 2023-06-30¥340.9bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-06-30¥650.4bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentrevenue external2023-04-01 → 2023-06-30¥340.9bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-06-30¥136.3bn
jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segmentsegment profit2023-04-01 → 2023-06-30¥62.7bn
—segment totalrevenue2023-01-01 → 2023-06-30¥949.2bn
—segment totalrevenue2023-04-01 → 2023-06-30¥500.2bn
—segment totalrevenue external2023-01-01 → 2023-06-30¥947.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥499.2bn
—segment totalrevenue intersegment2023-01-01 → 2023-06-30¥1.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥965m
—segment totalsegment profit2023-01-01 → 2023-06-30¥156.1bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥66.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 877
ItemContextValueUnit
Share based payment transactions ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember101000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember190000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-114000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-217000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember332000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember101000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember188000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-27246000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-217000000JPY
Total transactions with owners IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember332000000JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember81690000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember506681000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-44669000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember1628417000000JPY
Equity IFRSPrior1QuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior1QuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember52126000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember87503000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember20000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember128773000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember2225255000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember37114000000JPY
Equity IFRSPrior2YearInstant2262369000000JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember102594000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember2464000000JPY
Profit loss IFRSPrior1YTDDuration105058000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember115301000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember18000000JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember126082000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember126082000000JPY
Other comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember1245000000JPY
Other comprehensive income IFRSPrior1YTDDuration127328000000JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember115301000000JPY
Comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember18000000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember126082000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass